Archive Category: 10X Stocks Archive

Markets have plunged into a tailspin over the last few weeks — with investors scrambling for answers to critical questions about everything from trade balance and President Trump’s policies to simple supply and demand. So I took some time out to create a new Special Report that covers my entire 10X Stocks Big Picture Outlook for the markets and the year ahead.

Elon Musk’s Department of Government Efficiency (DOGE) has quickly become the biggest breakout success of the new Trump administration. A new Harvard CAPS/Harris poll revealed a 76% approval rating for the department. That shouldn’t come as a surprise, either… Government waste has long been an open secret in Washington. The bureaucracy on Capitol Hill has long been resistant to change, even when it comes to simply updating its technology. Even now, in the digital era, the government is still storing massive amounts of paper documents inside abandoned salt mines in Kansas.

One of our top-performing stocks has been on an absolute rollercoaster over the past few weeks … nearly becoming our first holding to cross the 10X threshold before tumbling back down to Earth. For this week’s issue, I wanted to share a special video “deep dive” into everything you need to know about Hims & Hers Heath Inc. (HIMS) — from my initial trade rationale up through the latest updates on the company’s miracle weight-loss drug. In short, I’m as bullish as ever … and I’m screaming “BUY” from the mountaintop.

Earlier this week, Hims & Hers Health (HIMS) announced its acquisition of Trybe Labs, a company specializing in at-home blood tests. On the surface, I realize this kind of news might not seem like a very big deal… After all, Hims’ GLP-1 drugs are already a medical miracle. Blood testing is a little mundane by comparison. But in reality, this was one of the biggest announcements in Hims’ history — laying down the groundwork for a growing telehealth empire and fast-tracking the company’s 10X prospects.

Two weeks ago, Chinese AI firm DeepSeek turned the tech world on its head with a breakthrough announcement. They’d developed a new AI that could rival ChatGPT for a fraction of the cost, which only required a fraction of the processing power. This announcement sent shares of Nvidia (NVDA) into an instant tailspin, with the stock crashing 17% and shedding a record-breaking $600 billion in market cap before the closing bell rang.